Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts
  2. Sithanandam, G.; Fornwald, L. W.; Fields, J. R.; Morris, N. L.; Anderson, L. M.
  3. International Journal of Cancer. 2012, Jan; 130(2): 251-258.
  1. 2.   Design and synthesis of paclitaxel conjugated with an ErbB2-Recognizing pepticle, EC-1
  2. Li, P.; Jiang, S.; Pero, S. C.; Oligino, L.; Krag, D. N.; Michejda, C. J.; Roller, P. P.
  3. Biopolymers. 2007, Nov; 87(4): 225-230.
  1. 3.   Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain
  2. Spuches, A. M.; Argiros, H. J.; Lee, K. H.; Haas, L. L.; Perch, S. C.; Krag, D. N.; Roller, P. P.; Wilcox, D. E.; Lyons, B. A.
  3. Journal of Molecular Recognition. 2007, Jul-Aug; 20(4): 245-252.
  1. 4.   Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549
  2. Sithanandam, G.; Fornwald, L. W.; Fields, J.; Anderson, L. M.
  3. Oncogene. 2005, MAR 10; 24(11): 1847-1859.
  1. 5.   Development of L-3-aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding affinity
  2. Song, Y. L.; Roller, P. P.; Long, Y. Q.
  3. Bioorganic & Medicinal Chemistry Letters. 2004 14(12): 3205-3208.
  1. 6.   Potentiating effect of distant sites in non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain
  2. Long, Y. Q.; Guo, R. B.; Luo, J. H.; Yang, D. J.; Roller, P. P.
  3. Biochemical and Biophysical Research Communications. 2003 310(2): 334-340.
  1. 7.   Cell cycle activation in lung adenocarcinoma cells by the ErbB3/phosphatidylinositol 3-kinase/Akt pathway
  2. Sithanandam, G.; Smith, G. T.; Masuda, A.; Takahashi, T.; Anderson, L. M.; Fornwald, L. W.
  3. Carcinogenesis. 2003 24(10): 1581-1592.
  1. 8.   Encapsidation and transduction of cellular genes by retroviruses
  2. Muriaux, D.; Rein, A.
  3. Frontiers in Bioscience. 2003 8: D135-D142.
  1. 10.   Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: Antiproliferative activity on human breast carcinoma cell lines
  2. Mandler, R.; Wu, C. C.; Sausville, E. A.; Roettinger, A. J.; Newman, D. J.; Ho, D. K.; King, C. R.; Yang, D. J.; Lippman, M. E.; Landolfi, N. F.; Dadachova, E.; Brechbiel, M. W.; Waldmann, T. A.
  3. Journal of the National Cancer Institute. 2000 92(19): 1573-1581.
  1. 11.   neu mutation in schwannomas induced transplacentally in Syrian golden hamsters by N-nitrosoethylurea: high incidence but low allelic representation
  2. Buzard, G. S.; Enomoto, T.; Hongyo, T.; Perantoni, A. O.; Diwan, B. A.; Devor, D. E.; Reed, C. D.; Dove, L. F.; Rice, J. M.
  3. Journal of Cancer Research and Clinical Oncology. 1999 125(10): 529-540.
  1. 12.   Activation of neu by missense point mutation in the transmembrane domain in schwannomas induced in C3H/HeNCr mice by transplacental exposure to N-nitrosoethylurea
  2. Buzard, G. S.; Enomoto, T.; Anderson, L. M.; Perantoni, A. O.; Devor, D. E.; Rice, J. M.
  3. Journal of Cancer Research and Clinical Oncology. 1999 125(12): 653-659.
  1. 13.   Novel mutations of the MET proto-oncogene in papillary renal carcinomas
  2. Schmidt, L.; Junker, K.; Nakaigawa, N.; Kinjerski, T.; Weirich, G.; Miller, M.; Lubensky, I.; Neumann, H. P. H.; Brauch, H.; Decker, J.; Vocke, C.; Brown, J. A.; Jenkins, R.; Richard, S.; Bergerheim, U.; Gerrard, B.; Dean, M.; Linehan, W. M.; Zbar, B.
  3. Oncogene. 1999 18(14): 2343-2350.
  1. 14.   Erbb Kinases and Ndf Signaling in Human Prostate Cancer Cells
  2. Grasso, A. W.; Wen, D. Z.; Miller, C. M.; Rhim, J. S.; Pretlow, T. G.; Kung, H. J.
  3. Oncogene. 1997 15(22): 2705-2716.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel